Adenosine mediates the amelioration of social novelty deficits during rhythmic light treatment of 16p11.2+/- female mice

Author:

Hou Sheng-Tao1,Ju Jun1ORCID,Li Xuanyi1,Yang Xinyi1,Du Jun,Men Siqi,Liu Bo,Zhang ZhenyuORCID,Zhong Haolin,Mai Jinyuan,Wang Yizheng2

Affiliation:

1. Southern University of Science and Technology

2. National Clinical Research Center for Aging and Medicine, Huashan HospitalFudan University

Abstract

Abstract Non-invasive brain stimulation therapy for autism spectrum disorder (ASD) has shown beneficial effects. Recently, visual sensory stimulation using rhythmic 40 Hz light flicker effectively improved cognitive deficits in mouse models of Alzheimer's disease and stroke. However, whether rhythmic visual 40 Hz light flicker stimulation can ameliorate behavioral deficits in ASD remains unknown. Here, we show that 16p11.2+/− female mice exhibit a strong social novelty deficit, which was ameliorated by treatment with a long-term 40 Hz light stimulation. The elevated power of local-field potential (LFP) in the prefrontal cortex (PFC) of 16p11.2+/− female mice was also effectively reduced by 40 Hz light treatment. Importantly, the 40 Hz light flicker reversed the excessive excitatory neurotransmission of PFC pyramidal neurons without altering the firing rate and the number of resident PFC neurons. Mechanistically, 40 Hz light flicker evoked adenosine release in the PFC to modulate excessive excitatory neurotransmission of 16p11.2+/− female mice. Elevated adenosine functioned through its cognate A1 receptor to suppress excessive excitatory neurotransmission and to alleviate social novelty deficits. Indeed, either blocking the A1 receptor using a specific antagonist DPCPX or knockdown the A1 receptor in the PFC using an shRNA completely ablated the beneficial effects of 40 Hz light flicker. Thus, this study identified adenosine as a novel neurochemical cause for ameliorating social novelty deficit through the reduction of excitatory neurotransmission by the 40 Hz light flicker. The 40 Hz light stimulation warrants further development as a non-invasive ASD therapeutics.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3